Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma

Weihua Qiu, Bingsen Zhou, Hongzhi Zou, Xiyong Liu, Peiguo G. Chu, Richard Lopez, Jennifer Shih, Christopher Chung, Yun Yen

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Growth arrest DNA damage-inducible gene 45 β (GADD45β) has been known to regulate cell growth, apoptotic cell death, and cellular response to DNA damage. Down-regulation of GADD45β has been verified to be specific in hepatocellular cancer (HCC) and consistent with the p53 mutant, and degree of malignancy of HCC. This observation was further confirmed by eight HCC cell lines and paired human normal and HCC tumor tissues by Northern blot and immunohistochemistry. To better understand the transcription regulation, we cloned and characterized the active promoter region of GADD45β in luciferase-expressing vector. Using the luciferase assay, three nuclear factor-κB binding sites, one E2F-1 binding site, and one putative inhibition region were identified in the proximal promoter of GADD45β from -865/+6. Of interest, no marked putative binding sites could be identified in the inhibition region between -520/-470, which corresponds to CpG-rich region. The demethylating agent 5-Aza-dC was used and demonstrated restoration of the GADD45β expression in HepG2 in a dose-dependent manner. The methylation status in the promoter was further examined in one normal liver cell, eight HCC cell lines, eight HCC tissues, and five corresponding nonneoplastic liver tissues. Methylation-specific polymerase chain reaction and sequencing of the sodium bisulfite-treated DNA from HCC cell lines and HCC samples revealed a high percentage of hypermethylation of the CpG islands. Comparatively, the five nonneoplastic correspondent liver tissues demonstrated very low levels of methylation. To further understand the functional role of GADD45β under-expression in HCC the GADD45β cDNA constructed plasmid was transfected into HepG2 (p53 WT) and Hep3B (p53 null) cells. The transforming growth factor-β was assayed by enzyme-linked immunosorbent assay, which revealed a decrease to 40% in transfectant of HepG2, but no significant change in Hep3B transfectant. Whereas, Hep3B co-transfected with p53 and GADD45β demonstrated significantly reduced transforming growth factor-β. The colony formation was further examined and revealed a decrease in HepG2-GADD45β transfectant and Hep3B-p53/GADD45β co-transfectant. These findings suggested that methylation might play a crucial role in the epigenetic regulation of GADD45β in hepatocyte transformation that may be directed by p53 status. Thus, our results provided a deeper understanding of the molecular mechanism of GADD45β down-regulation in HCC.

Original languageEnglish (US)
Pages (from-to)1689-1699
Number of pages11
JournalAmerican Journal of Pathology
Volume165
Issue number5
StatePublished - Nov 2004

Fingerprint

DNA Damage
Hepatocellular Carcinoma
Liver Neoplasms
Growth
Genes
Methylation
Binding Sites
Transforming Growth Factors
Luciferases
Cell Line
Liver
Down-Regulation
Null Lymphocytes
CpG Islands
Genetic Promoter Regions
Epigenomics
Northern Blotting
Hepatocytes
Neoplasms
Plasmids

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Qiu, W., Zhou, B., Zou, H., Liu, X., Chu, P. G., Lopez, R., ... Yen, Y. (2004). Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma. American Journal of Pathology, 165(5), 1689-1699.

Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma. / Qiu, Weihua; Zhou, Bingsen; Zou, Hongzhi; Liu, Xiyong; Chu, Peiguo G.; Lopez, Richard; Shih, Jennifer; Chung, Christopher; Yen, Yun.

In: American Journal of Pathology, Vol. 165, No. 5, 11.2004, p. 1689-1699.

Research output: Contribution to journalArticle

Qiu, W, Zhou, B, Zou, H, Liu, X, Chu, PG, Lopez, R, Shih, J, Chung, C & Yen, Y 2004, 'Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma', American Journal of Pathology, vol. 165, no. 5, pp. 1689-1699.
Qiu, Weihua ; Zhou, Bingsen ; Zou, Hongzhi ; Liu, Xiyong ; Chu, Peiguo G. ; Lopez, Richard ; Shih, Jennifer ; Chung, Christopher ; Yen, Yun. / Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma. In: American Journal of Pathology. 2004 ; Vol. 165, No. 5. pp. 1689-1699.
@article{ea11166202cf405fa451d3ace85d63ee,
title = "Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma",
abstract = "Growth arrest DNA damage-inducible gene 45 β (GADD45β) has been known to regulate cell growth, apoptotic cell death, and cellular response to DNA damage. Down-regulation of GADD45β has been verified to be specific in hepatocellular cancer (HCC) and consistent with the p53 mutant, and degree of malignancy of HCC. This observation was further confirmed by eight HCC cell lines and paired human normal and HCC tumor tissues by Northern blot and immunohistochemistry. To better understand the transcription regulation, we cloned and characterized the active promoter region of GADD45β in luciferase-expressing vector. Using the luciferase assay, three nuclear factor-κB binding sites, one E2F-1 binding site, and one putative inhibition region were identified in the proximal promoter of GADD45β from -865/+6. Of interest, no marked putative binding sites could be identified in the inhibition region between -520/-470, which corresponds to CpG-rich region. The demethylating agent 5-Aza-dC was used and demonstrated restoration of the GADD45β expression in HepG2 in a dose-dependent manner. The methylation status in the promoter was further examined in one normal liver cell, eight HCC cell lines, eight HCC tissues, and five corresponding nonneoplastic liver tissues. Methylation-specific polymerase chain reaction and sequencing of the sodium bisulfite-treated DNA from HCC cell lines and HCC samples revealed a high percentage of hypermethylation of the CpG islands. Comparatively, the five nonneoplastic correspondent liver tissues demonstrated very low levels of methylation. To further understand the functional role of GADD45β under-expression in HCC the GADD45β cDNA constructed plasmid was transfected into HepG2 (p53 WT) and Hep3B (p53 null) cells. The transforming growth factor-β was assayed by enzyme-linked immunosorbent assay, which revealed a decrease to 40{\%} in transfectant of HepG2, but no significant change in Hep3B transfectant. Whereas, Hep3B co-transfected with p53 and GADD45β demonstrated significantly reduced transforming growth factor-β. The colony formation was further examined and revealed a decrease in HepG2-GADD45β transfectant and Hep3B-p53/GADD45β co-transfectant. These findings suggested that methylation might play a crucial role in the epigenetic regulation of GADD45β in hepatocyte transformation that may be directed by p53 status. Thus, our results provided a deeper understanding of the molecular mechanism of GADD45β down-regulation in HCC.",
author = "Weihua Qiu and Bingsen Zhou and Hongzhi Zou and Xiyong Liu and Chu, {Peiguo G.} and Richard Lopez and Jennifer Shih and Christopher Chung and Yun Yen",
year = "2004",
month = "11",
language = "English (US)",
volume = "165",
pages = "1689--1699",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatocellular carcinoma

AU - Qiu, Weihua

AU - Zhou, Bingsen

AU - Zou, Hongzhi

AU - Liu, Xiyong

AU - Chu, Peiguo G.

AU - Lopez, Richard

AU - Shih, Jennifer

AU - Chung, Christopher

AU - Yen, Yun

PY - 2004/11

Y1 - 2004/11

N2 - Growth arrest DNA damage-inducible gene 45 β (GADD45β) has been known to regulate cell growth, apoptotic cell death, and cellular response to DNA damage. Down-regulation of GADD45β has been verified to be specific in hepatocellular cancer (HCC) and consistent with the p53 mutant, and degree of malignancy of HCC. This observation was further confirmed by eight HCC cell lines and paired human normal and HCC tumor tissues by Northern blot and immunohistochemistry. To better understand the transcription regulation, we cloned and characterized the active promoter region of GADD45β in luciferase-expressing vector. Using the luciferase assay, three nuclear factor-κB binding sites, one E2F-1 binding site, and one putative inhibition region were identified in the proximal promoter of GADD45β from -865/+6. Of interest, no marked putative binding sites could be identified in the inhibition region between -520/-470, which corresponds to CpG-rich region. The demethylating agent 5-Aza-dC was used and demonstrated restoration of the GADD45β expression in HepG2 in a dose-dependent manner. The methylation status in the promoter was further examined in one normal liver cell, eight HCC cell lines, eight HCC tissues, and five corresponding nonneoplastic liver tissues. Methylation-specific polymerase chain reaction and sequencing of the sodium bisulfite-treated DNA from HCC cell lines and HCC samples revealed a high percentage of hypermethylation of the CpG islands. Comparatively, the five nonneoplastic correspondent liver tissues demonstrated very low levels of methylation. To further understand the functional role of GADD45β under-expression in HCC the GADD45β cDNA constructed plasmid was transfected into HepG2 (p53 WT) and Hep3B (p53 null) cells. The transforming growth factor-β was assayed by enzyme-linked immunosorbent assay, which revealed a decrease to 40% in transfectant of HepG2, but no significant change in Hep3B transfectant. Whereas, Hep3B co-transfected with p53 and GADD45β demonstrated significantly reduced transforming growth factor-β. The colony formation was further examined and revealed a decrease in HepG2-GADD45β transfectant and Hep3B-p53/GADD45β co-transfectant. These findings suggested that methylation might play a crucial role in the epigenetic regulation of GADD45β in hepatocyte transformation that may be directed by p53 status. Thus, our results provided a deeper understanding of the molecular mechanism of GADD45β down-regulation in HCC.

AB - Growth arrest DNA damage-inducible gene 45 β (GADD45β) has been known to regulate cell growth, apoptotic cell death, and cellular response to DNA damage. Down-regulation of GADD45β has been verified to be specific in hepatocellular cancer (HCC) and consistent with the p53 mutant, and degree of malignancy of HCC. This observation was further confirmed by eight HCC cell lines and paired human normal and HCC tumor tissues by Northern blot and immunohistochemistry. To better understand the transcription regulation, we cloned and characterized the active promoter region of GADD45β in luciferase-expressing vector. Using the luciferase assay, three nuclear factor-κB binding sites, one E2F-1 binding site, and one putative inhibition region were identified in the proximal promoter of GADD45β from -865/+6. Of interest, no marked putative binding sites could be identified in the inhibition region between -520/-470, which corresponds to CpG-rich region. The demethylating agent 5-Aza-dC was used and demonstrated restoration of the GADD45β expression in HepG2 in a dose-dependent manner. The methylation status in the promoter was further examined in one normal liver cell, eight HCC cell lines, eight HCC tissues, and five corresponding nonneoplastic liver tissues. Methylation-specific polymerase chain reaction and sequencing of the sodium bisulfite-treated DNA from HCC cell lines and HCC samples revealed a high percentage of hypermethylation of the CpG islands. Comparatively, the five nonneoplastic correspondent liver tissues demonstrated very low levels of methylation. To further understand the functional role of GADD45β under-expression in HCC the GADD45β cDNA constructed plasmid was transfected into HepG2 (p53 WT) and Hep3B (p53 null) cells. The transforming growth factor-β was assayed by enzyme-linked immunosorbent assay, which revealed a decrease to 40% in transfectant of HepG2, but no significant change in Hep3B transfectant. Whereas, Hep3B co-transfected with p53 and GADD45β demonstrated significantly reduced transforming growth factor-β. The colony formation was further examined and revealed a decrease in HepG2-GADD45β transfectant and Hep3B-p53/GADD45β co-transfectant. These findings suggested that methylation might play a crucial role in the epigenetic regulation of GADD45β in hepatocyte transformation that may be directed by p53 status. Thus, our results provided a deeper understanding of the molecular mechanism of GADD45β down-regulation in HCC.

UR - http://www.scopus.com/inward/record.url?scp=7244239107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244239107&partnerID=8YFLogxK

M3 - Article

C2 - 15509538

AN - SCOPUS:7244239107

VL - 165

SP - 1689

EP - 1699

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -